$1.66
0.021.22%
At close: -
$1.61
-0.05-3.01%
After Hours: Apr 3, 9:25 AM EDT
Comments
Loading...
Whitehawk Therapeutics Analyst Ratings and Price Targets | NASDAQ:WHWK | Benzinga
Whitehawk Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Whitehawk Therapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for Whitehawk Therapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Whitehawk Therapeutics (WHWK) stock?
There is no price target for Whitehawk Therapeutics
What is the most recent analyst rating for Whitehawk Therapeutics (WHWK)?
There is no analyst for Whitehawk Therapeutics
When was the last upgrade for Whitehawk Therapeutics (WHWK)?
There is no last upgrade for Whitehawk Therapeutics
When was the last downgrade for Whitehawk Therapeutics (WHWK)?
There is no last downgrade for Whitehawk Therapeutics.
When is the next analyst rating going to be posted or updated for Whitehawk Therapeutics (WHWK)?
There is no next analyst rating for Whitehawk Therapeutics.
Is the Analyst Rating Whitehawk Therapeutics (WHWK) correct?
There is no next analyst rating for Whitehawk Therapeutics.
Browse analyst ratings and price targets on all stocks.